The fragile X syndrome is the most common cause of inherited mental retardation resulting from the absence of the fragile X mental retardation protein (FMRP). FMRP contains two K-homology (KH) domains and one RGG box that are landmarks characteristic of RNA-binding proteins. In agreement with this, FMRP associates with messenger ribonucleoparticles (mRNPs) within actively translating ribosomes, and is thought to regulate translation of target mRNAs, including its own transcript. To investigate whether FMRP might chaperone nucleic acid folding and hybridization, we analysed the annealing and strand exchange activities of DNA oligonucleotides and the enhancement of ribozymedirected RNA substrate cleavage by FMRP and deleted variants relative to canonical nucleic acid chaperones, such as the cellular YB-1/p50 protein and the retroviral nucleocapsid protein HIV-1 NCp7. FMRP was found to possess all the properties of a potent nucleic acid chaperone, requiring the KH motifs and RGG box for optimal activity. These ®nd-ings suggest that FMRP may regulate translation by acting on RNA±RNA interactions and thus on the structural status of mRNAs.
INTRODUCTION
The fragile X syndrome is the most common cause of inherited mental retardation in humans resulting from the absence of the FMR1 gene product, the FMR1 protein [fragile X mental retardation protein (FMRP)] (1, 2) . FMRP is a protein of 632 amino acids composed, in N-terminus to C-terminus order, of a protein-interacting domain (PPId), two K-homology (KH) motifs, a phosphorylation sequence and an RNA recognition sequence called the RGG box (1±3). FMRP is widely expressed, but most abundant in testes and brain, which are the organs strongly affected by the syndrome (4, 5) .
The cellular role of FMRP remains poorly understood and the current view is that it regulates mRNA transport and translation in a manner critical for the development of neurons (6, 7) . To achieve its function, FMRP is thought to be engaged in a number of interactions with cytoplasmic nucleic acid and protein partners (1,8±15) in association with messenger ribonucleoparticles (mRNPs) in actively translating ribosomes (16, 17) , however, the exact role of FMRP in translation remains elusive. Several studies have shown that FMRP can act as a negative regulator of translation in vitro and in vivo (18±20) and it has been proposed that in neurons a small fraction of FMRP acts as a repressor for the RNA to be transported and to be delivered at the budding dendrites (20) . Indeed, while the great majority of FMRP has been observed in the neuron cell body, a small fraction was detected at distal locations such as neurites, dendrites and synaptosomes (5, 21, 22) . A series of neuronal mRNAs have been isolated either by immunoprecipitation approaches (8) , or by the use of a new technique called`APRA' for antibody positioned RNA ampli®cation (24) . In addition, several target mRNAs have been isolated by differential display, by oligonucleotide (ODN)-based and by cDNA-SELEX (9, 25, 26) . Also it has been reported that FMRP interacts with small noncoding RNAs such as BC1 and BC200, which in turn mediates their binding to speci®c mRNAs (27) . These observations clearly indicate that FMRP has af®nity to RNAs, however, it is not clear whether all these target mRNAs bind directly to FMRP or if FMRP protein interactors are required.
In view of the binding of FMRP to mRNAs and small noncoding RNAs, we addressed the question as to whether FMRP might be a nucleic acid chaperone protein. So-called nucleic acid chaperones bind in a cooperative manner to one or more nucleic acid molecules and promote the formation of the most stable structure while at the same time preventing folding traps that may preclude function (28, 29) . Importantly, nucleic acid chaperones do not require ATP to function and once the most stable nucleic acid structure is achieved, their continued binding is no longer required to maintain the structure (28, 29) .
Canonical nucleic acid chaperones, such as retroviral NC proteins, are able to anneal, under physiological conditions in vitro, a speci®c primer tRNA to a complementary sequence at the 5¢ end of genomic viral RNA; a prerequisite for the initiation of reverse transcription (30, 31) .
In the present study, we examined the ability of FMRP to chaperone the annealing of DNA with complementary sequences as well as strand exchange in a duplex nucleic acid structure in vitro. Furthermore, we investigated whether FMRP is capable of enhancing ribozyme-directed cleavage of an RNA substrate in vitro. Our results show that FMRP is a potent chaperone protein.
MATERIALS AND METHODS

Recombinant proteins
The full-length FMRP and six deleted variants DPPId, DKH1, DKH2, DKHT (DKH1 plus DKH2), DPhD and DRGG FMRP with a C-terminal (His)6-tag were produced in Escherichia coli and puri®ed to homogeneity by af®nity chromatography using Ni-NTA Probond beads (Invitrogen) according to the manufacturer's protocol as previously described ( Fig. 1) (3) .
HIV-1 nucleocapsid protein NCp7 and mutant NC(12±53) were synthesized by the fmoc/opfp chemical method and puri®ed to >98% purity by high-pressure liquid chromatography (30) . Proteins were dissolved at 1 mg/ml in buffer containing 30 mM HEPES pH 6.5, 30 mM NaCl and 0.1 mM ZnCl 2 .
The YB-1/p50 protein (32) was a kind gift from Lev Ovchinnikov (Moscow, Russia) (31).
DNA substrates
DNA ODNs corresponding to the HIV-1 TAR and the repeated R sequences (Mal isolate), in the sense and anti-sense orientation were purchased from Eurogentec (Belgium). TAR and R ODNs are 56 and 96 nt in length, respectively. TAR(+) (sense) (30): 5¢-GGTCTCTCTTGTTAGACC-AGGTCGAGCCCGGGAGCTCTCTGGCTAGCAAGGA-ACCC-3¢; TAR(±) (anti-sense): 5¢-GGGTTCCTTGCTAGC-CAGAGAGCTCCCGGGCTCGACCTGGTCTAACAAG-AGAGACC-3¢; R(+).wt (sense): 5¢-GGTCTCTCTTGTT-AGACCAGGTCGAGCCCGGGAGCTCTCTGGCTAGC-AAGGAACCCACTGCTTAAGCCTCAATAAAGCTTGC-CTTGAGTGCCTCCC-3¢; R(-).wt (anti-sense): 5¢-GGGAG-GCACTCAAGGCAAGCTTTATTGAGGCTTAAGCAGT-GGGTTCCTTGCTAGCCAGAGAGCTCCCGGGCTCGA-CCTGGTCTAACAAGAGAGACC-3¢.
DNA ODNs corresponding to R(±) in which 7 nt were mutated at the 3¢ end (underlined nucleotide): R(±).3¢-modi®ed: 5¢.GGGAGGCACTCAAGGCAAGCTTTATTG-AGGCTTAAGCAGTGGGTTCCTTGCTAGCCAGAGAG-CTCCCGGGCTCGACCTGGTCTAACATCAGTCTCTA-3¢; TAR(±) and R(+) ODNs were 32 P-labelled with 50 mCi of [g-32 P]ATP using T4 polynucleotide kinase. 32 P-labelled DNAs TAR(±) and R(+) were puri®ed by 10% PAGE, 7 M urea in 50 mM Tris-borate, 1 mM EDTA, pH 8.3 (0.5Q TBE) before use.
Plasmid DNAs
Plasmid DNAs pS14, pS20 and pR3 were kindly provided by E. Bertrand (33) . All plasmid DNAs were ampli®ed in E.coli 1035 (RecA-) and puri®ed by af®nity chromatography (Qiagen protocol).
In vitro RNA synthesis
RNAs were labelled with [a-32 P]UTP during in vitro transcription, as previously described (31), using T7 RNA polymerase. Template DNAs pS14, pS20 and pR3 were digested with PstI, ®rst treated by Klenow to remove the 3¢ strand overhang and substrate RNA and the ribozyme generated by in vitro transcription with the following modi®cations: for substrate RNA (transcription of pS14 and pS20 DNA) the concentration of UTP was 10 mM and 50 mCi [a-32 P]UTP (Amersham, UK) were added. For the ribozyme (pR3 DNA template), the concentration of UTP was 100 mM and 10 mCi of [a-32 P]UTP were added.
Following in vitro RNA synthesis, the DNA template was removed by treatment with RNase-free DNase I (Promega) for 20 min at 37°C, followed by phenol and chloroform extractions, and ethanol precipitation. All 32 P-labelled RNAs were 
TAR(±)/TAR(+) annealing assays
HIV-1 TAR(+) and 32 P-labelled TAR(±) ODNs were incubated (0.015 pmol, each equivalent to a DNA concentration of 3 Q 10 ±9 M) with or without protein in 10 ml containing 20 mM Tris±HCl (pH 7.0), 30 mM NaCl, 0.1 mM MgCl 2, 10 mM ZnCl 2 and 5 mM DTT. Reactions were performed at 37°C for 10 min except for the positive control which was kept at 65°C for 30 min under oil. Reactions were stopped with 5 ml of 20% glycerol, 20 mM EDTA pH 8.0, 0.2% SDS, 0.25% bromophenol blue and 0.4 mg/ml calf liver tRNA. Samples were analysed by 8% native PAGE in 0.5Q TBE and, subsequently, gels were autoradiographed. Quantitation was by PhosphorImaging.
DNA strand transfer and exchange assays 0.03 pmol of 32 P-labelled R(+).wt, 0.03 pmol of R(±). 3¢-modi®ed and 0.03 pmol of R(±).wt were separately heat denatured for 2 min at 90°C and chilled on ice. All components were kept at 4°C. 0.03 pmol each of 32 P-labelled R(+).wt and R(±).3¢-modi®ed, at a concentration of 6 Q 10 ±8 M, were mixed with reaction buffer to a ®nal concentration of 20 mM Tris±HCl, pH 7.0, 30 mM NaCl, 0.1 mM MgCl 2 , 10 mM ZnCl 2 and 5 mM DTT in 5 ml ®nal volume, incubated for 30 min at 62°C under oil and chilled on ice. Then, 0.03 pmol of R(±).wt was added together with the protein using a protein to nucleotide molar ratio as indicated in the legends. Assays were for 5 min at 37°C, they were then chilled on ice and stopped with 2.5 ml of 20% glycerol, 20 mM EDTA pH 8.0, 0.2% SDS, 0.25% bromophenol blue and 0.4 mg/ml calf liver tRNA. Samples were resolved by 6% native PAGE in 0.5Q TBE at 4°C and, subsequently, gels were autoradiographed. Quantitation was by PhosphorImaging.
Hammerhead ribozyme cleavage assays
Ribozyme and substrate RNA were independently heated for 1 min at 90°C in H 2 O. The reaction buffer was added to yield ®nal concentrations of 5 mM MgCl 2 , 100 mM NaCl, 20 mM Tris±HCl, pH 7.5. After slow cooling to 37°C, RNAs were further incubated for 5 min at 20°C. 0.1 pmol of ribozyme and 0.02±2 pmol of RNA substrate were then combined in a ®nal volume of 10 ml, each protein was added to the ®nal ratio indicated in the legend of the ®gures and incubation was for 25 min at 37°C. Reactions were terminated by adding 20 ml of stop solution (0.3% SDS, 15 mM EDTA), extracted with 30 ml of phenol and 15 ml of chloroform. The aqueous phase was precipitated with ethanol and the pellet resuspended in 45% formamide, 0.5Q TBE, and 0.1% dye. 32 P-labelled RNAs were analysed on 8% PAGE in 0.5Q TBE and, subsequently, gels were autoradiographed. Quantitation was by PhosphorImaging.
RESULTS
FMRP and the deleted versions (denoted DPPId, DKH1, DKH2, DKHT, DPhd and DRGG) were expressed in E.coli with a C-terminal (His)6-tag and puri®ed by Ni-chelate chromatography (see Materials and Methods). HIV-1 NCp7 and its truncated version denoted DNC(12±53) were synthesized and puri®ed according to a published procedure (30) . YB-1/p50 was provided by Lev Ovchinnikov (32) (Fig. 1) . To con®rm that FMRP stably binds nucleic acids and RNA in particular, we examined by native gel electrophoresis the formation of nucleoprotein complexes between FMRP and either tRNA Lys,3 , BC1 or BC200, at concentrations of 10 ±8 M. 
FMRP has DNA annealing activity
To assay for nucleic acid chaperone activity, FMRP was examined for its ability to enhance the annealing of complementary DNA ODNs (Fig. 2A) . To this end, complementary 32 P-Tar(±) and Tar(+) ODNs (56 nt) were incubated in the presence of increasing concentrations of FMRP, subsequently chased with a tRNA excess. Duplex formation was analysed by native gel electrophoresis.
Results show that addition of FMRP caused nearly complete duplex formation [Fig. 2B , compare lanes 1±3 in (2) with lane 2 in (1)]. This effect is not simply due to enhanced molecular crowding, since at the same protein concentration, BSA did not enhance duplex formation (data not shown). Also, the propensity of FMRP to anneal the TAR substrates is not simply a general feature of DNA binding proteins, since at similar concentrations, the single-stranded We also examined the ability of FMRP to promote the hybridization of replication primer tRNA Lys,3 to a complementary sequence at the 5¢ end of the HIV-1 genomic RNA, called the primer binding site. Indeed, FMRP was able to hybridize the cellular tRNA to the viral RNA (Supplementary ®g. 2; lanes 2±5).
FMRP has DNA strand exchange activity
Another property of nucleic acid chaperones is to direct the formation of the most stable nucleic acid conformation. This can be assayed by examining the strand exchange activity of the protein (Fig. 3A ). An imperfect DNA duplex with two partially complementary ODNs is formed by heating at 62°C. Then, the chaperone is added together with another ODN with the potential to form a perfect duplex with one of the two initial ODNs. After incubation under physiological conditions, the protein is removed and the ratio of the two DNA duplexes, the perfect duplex and the one containing seven mismatches, is assessed by native gel electrophoresis. As shown in Figure 3B (lanes 14±16), FMRP exchanged the matched strand [R(±).wt] for the mismatched strand [R(±).mut] as observed with HIV-1 NCp7 (lanes 5±7). FMRP was more active than p50 (lanes 11± 13). In contrast, the level of the mismatched duplex remained unaffected by BSA, T4gp32 (30,31,34 and data not shown) or mutant NC(12±53) (compare lanes 8±10 and 14±16). The FMRP domains, such as PPId, KH and Phd, appeared to be critical for full activity (lanes 17±34).
Taken together, these results indicate that FMRP does indeed possess DNA annealing and strand exchange activities, which are properties expected for a nucleic acid chaperone (28, 29) , and that several domains, including the PPId, KH and RGG motifs, are important determinants for these activities.
Enhancement of ribozyme cleavage of an RNA substrate by FMRP
Cleavage of an RNA substrate by a hammerhead ribozyme is a model system which allows examination of both the RNA annealing and unwinding activities of nucleic acid chaperone proteins. Chaperones can enhance the rate of ribozyme cleavage by activating the annealing of the substrate RNA to the hammerhead ribozyme (Fig. 4A, step 1 ) and the release of the RNA products (Fig. 4A, step 3) , thus allowing cyclic reuse of the ribozyme (31, 38) . The ribozyme cleavage assay intends to investigate whether FMRP enhances ribozyme cleavage of an RNA substrate in a manner similar to NCp7 and hnRNP A1 chaperone proteins (see Fig. 4A) (33,38) .
We selected the R3 hammerhead ribozyme and two RNA substrates, namely S14, with a 14 nt substrate ribozyme duplex length (7 nt either side of the cleavage site) and S20, with 10 nt either side of the cleavage site. The above RNA substrates were selected due to their likely biological relevance, as indicated by the similarity of data obtained in vitro and in cultured cells (33) . 32 P-labelled RNA S14, the hammerhead ribozyme and FMRP were mixed, incubated at 37°C for 25 min, protein removed by phenol extraction and RNA products recovered and analysed by PAGE under denaturing conditions. In the absence of a nucleic acid chaperone, ribozymedirected cleavage of the RNA substrate occurred slowly at 37°C (Fig. 4B, top , lanes 1 at 4°C and 2 at 37°C; 32 P-RNA substrate is S14 and upon cleavage it is DS14). In agreement with previous reports (33), HIV-1 NCp7 caused extensive ribozyme-directed cleavage of S14 RNA (lanes 3±5). On the other hand, NC(12±53) was poorly active (lanes 6±8). Interestingly, FMRP showed a clear enhancement of ribozyme-directed cleavage of S14 RNA (lanes 9±11). Deleted versions of FMRP, namely DPPId and DKHT were found to Figure 4 . Enhancement of ribozyme cleavage by FMRP. (A) Assay schematic. RNA substrate and hammerhead ribozyme, both 32 P-labelled, were generated by in vitro transcription and puri®ed by PAGE. Cleavage of the 32 P-labelled RNA substrate by the hammerhead ribozyme ®rst necessitates hybridization of the ribozyme to the substrate (step 1). After substrate cleavage (step 2, see arrow head), the RNA products must be released to allow recycling of the ribozyme (step 3). At the end of the reaction, protein is removed by phenol extraction and 32 P-labelled RNAs analysed by PAGE under denaturing conditions to visualize the 32 P-labelled RNA products. In the absence of a nucleic acid chaperone, annealing of the substrate to the ribozyme and release of the RNA products appear to be slow. Addition of a nucleic acid chaperone will accelerate hybridization of the substrate to the ribozyme and dissociation of the RNA products, and thus ribozyme turnover. Base pairing between the RNA substrate and ribozyme R3 are underlined on the substrate sequence. Ribozyme-mediated cleavage occurs on the 3¢ side of A (space) for RNA S14, ...GAUUAAGUAGUA AGAGUGUCUGCA-3¢, and for RNA S20, ...GAUUAAGUAGUA AGAGUGUCUGCA-3¢. (B) Ribozyme-directed cleavage of RNA substrate. Percentages of ribozyme-directed RNA cleavage at 25 min were assessed by PhorphorImaging and are indicated in parentheses (see below). The vertical arrow shows the direction of electrophoresis. Ribozyme R3 (0.3 pmol) and RNA S14 (0.1 pmol) were incubated as described in Materials and Methods. 32 P-labelled RNA substrate (S14) and product (DS14) were analysed by denaturing 8% PAGE in 0.5Q TBE. Lanes 1±2, R3 and S14 at 4 or 37°C for 30 min (5% and 20%). Reactions with proteins were for 15 min at 37°C. Lanes 3±5, HIV-1 NCp7 at protein to nucleotide molar ratios of 1:20, 1:10 and 1:5, respectively (60, 73 and 75%), corresponding to a protein concentration of 0.5, 1 and 2 Q 10 ±7 M, respectively. Lanes 6±8, NC(12±53) at molar ratios of 1:2.5, 1:1.2 and 1:0.6, respectively (25% for all ratios), corresponding to a protein concentration of 4, 8 and 16 Q 10 ±7 M, respectively. Lanes 9±11, FMRP at protein to nucleotide molar ratios of 1:20, 1:10 and 1:5, respectively (33, 45 and 66%), corresponding to a protein concentration of 0.5, 1 and 2 Q 10 ±7 M, respectively. Respective concentrations of the FMRP variants (lanes 12±20) were the same (see below). Lanes 12±14, FMRP DPPId at molar ratios of 1:20, 1:10 and 1:5, respectively (30, 35 and 39%) . Lanes 15±17, FMRP DKHT at molar ratios of 1:20, 1:10 and 1:5, respectively (25, 28 and 32%) . Lanes 18±20, FMRP DRGG at molar ratios of 1:20, 1:10 and 1:5, respectively (30, 40 and 57%) . R3, S14 and the 5¢ sequences of S14 (DS14) are identi®ed on the right. Markers are on the left. Note that the RNA products rapidly accumulate in the presence of a chaperone like NCp7 (lanes 3±5) or FMRP (lanes 9±11), whereas they do so only slowly in the absence of a chaperone (lane 2). (C) Ribozyme-directed cleavage of RNA substrate S20. Ribozyme R3 (0.3 pmol) and RNA S20 (0.1 pmol) were incubated as described in Materials and Methods. 32 P-labelled RNA substrate (S20) and product (DS20) were analysed by denaturing 8% PAGE in 0.5Q TBE. Lanes 1±2, R3 and S20 at 4 or 37°C for 30 min (5 and 25%). poorly enhance ribozyme-directed cleavage of S14 RNA (lanes 12±14 and 15±17, respectively). The DRGG deleted version of FMRP proved to be~3-fold less active than complete FMRP (lanes 18±20).
Next, we examined the effects of FMRP using RNA substrate S20, which is able to form an extended duplex of 20 nt with the hammerhead ribozyme (Fig. 4A) and which prevents activation of ribozyme cleavage by HIV-1 NCp7 or hnRNP A1 (33, 38) . In the absence of a chaperone, only minimal ribozyme-directed cleavage of RNA S20 was observed at 37°C (Fig. 4B, bottom, lanes 1 and 2) in contrast to what was seen with RNA S14 (Fig. 4B, top) . NCp7 did not enhance ribozyme cleavage of RNA S20, in agreement with previous data (lanes 3±4) (31) . FMRP and deleted versions were also found to exhibit very little, if any, enhancing activity using RNA S20 (bottom, lanes 7±14).
DISCUSSION
FMRP is not only an RNA-binding protein (Supplementary ®g. 1), but is also a nucleic acid chaperone, thus providing nucleic acid remodelling properties for this cellular protein. This conclusion is supported by several lines of evidence. FMRP promotes the hybridization of complementary DNAs under low ionic strength conditions (Fig. 2) , directs formation of the most stable duplex structure by achieving strand exchange and, once nucleic acid molecules have been refolded into their most stable structure, the protein is no longer required to maintain the structure (Fig. 3) . FMRP enhances ribozyme-directed cleavage of an RNA substrate, most probably by activating substrate RNA annealing to the ribozyme in physiological relevant conditions (Fig. 4) . In agreement with these ®ndings, FMRP can promote the hybridization of replication primer tRNA Lys3 to a complementary sequence at the 5¢ end of the HIV-1 genomic RNA, called the primer binding site (Supplementary ®g. 2) (34, 35) . According to these criteria, FMRP resembles the YB-1/p50 protein, which is a ubiquitous cellular chaperone (32) bound to mRNPs, involved in mRNA metabolism and in the regulation of translation (39) including its own transcript (40) .
Deleted variants of FMRP, namely, DPPId, DKH1, DKH2, DKH1/KH2 (DKHT), DPhd and DRGG (Fig. 1) , were examined for their ability to activate the annealing of complementary sequences, the strand exchange process and for their ability to enhance ribozyme cleavage of an RNA substrate (Figs 2±4). The results of these analyses on the chaperoning properties of the deleted variants of FMRP reveal that all the aforementioned domains are required for full activity. More precisely, deletion of only the PPId domain or the two KH motifs caused the strongest reduction in nucleic acid chaperoning directed by FMRP (Figs 3 and 4) . These results suggest that several domains of FMRP may need to simultaneously make contact with a nucleic acid molecule to effectively direct its transconformation, in common with the viral nucleocapsid protein (35) . Since the PPId domain is required for full activity, FMRP probably achieves nucleic acid chaperoning when it is in a dimeric form. If two or more RNA/DNA species with complementary sequences are present, binding of FMRP will generate a network of protein±nucleic acid and protein± protein interactions to induce refolding and hybridization of the RNA/DNA molecules involved (Figs 2±4).
FMRP is associated with mRNPs complexes, which shuttle between translating ribosomes and cytoplasmic granules in cells (20) . The emerging picture proposes that FMRP modulates translation through a network of protein±RNA and protein±protein interactions. According to our ®ndings, FMRP should also act on mRNA metabolism and translation by means of RNA±RNA interactions. These interactions might be under the control of non-coding RNA, as proposed for BC1 RNA (27) , or by causing mRNA dimerization by intermolecular G-quartet formation (9, 10, 15) . By analogy with YB-1/ p50, a major cellular chaperone associated with mRNPs (32, 39) , it can also be envisioned that a low level of FMRP should stimulate translation, whereas a high level of FMRP should mask the mRNA and hence inhibit its translation (20, 23, 29) . In support of this notion, recruitment of FMRP into mRNPs and polyribosomes in vivo is abolished upon deletion of either the PPId domain or the KH motifs (3). Interestingly, these very same domains are important determinants of the nucleic acid chaperoning activities of FMRP in vitro, suggesting that FMRP needs all its nucleic acid binding and chaperoning activities to exert its chaperone function in vivo. Our results open new perspectives on the functional role(s) of FMRP in RNA metabolism. Further analyses are required to investigate these functional aspects.
